Skip to main content
SpringerLink
Log in

The Selection of Data Sources For Use in Modelling Studies

  • Review Article
  • Data Sources in Modelling Studies
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Summary

Economic analysis has become increasingly important in healthcare in general, and particularly with respect to pharmaceuticals. Therefore, it is vital that the methods used in such evaluations are carefully scrutinised and refined. However, guidelines contain only a limited number of recommendations for the use of secondary data in modelling studies.

In this manuscript, the selection of data sources in modelling studies will be addressed. The objectives of this manuscript are as follows: (i) to present a general strategy on how to determine the appropriateness of a data source for a model; and (ii) to present recommendations on a transparent reporting format for the selection of data sources.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Australia Commonwealth Department of Health, Housing and Community Services. Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee. Canberra: Commonwealth Department, 1992

    Google Scholar 

  2. Commonwealth of Australia Department of Human Services and Health. Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee including major submissions involving economic analysis. Canberra: Australian Government Publishing Service, 1995

    Google Scholar 

  3. Canadian Coordinating Office for Health Technology Assessment (CCOHTA). Guidelines for economic evaluation of pharmaceuticals: Canada. 1st ed. Ottawa: CCOHTA, 1994

    Google Scholar 

  4. Ontario guidelines for economic analysis of pharmaceutical products. Ontario: Canadian Ministry of Health, Drug Programs Branch, 1993

  5. Weinstein MC, Fineberg HV. Clinical decision analysis. Philadelphia: WB Saunders Co., 1980: 228–65

    Google Scholar 

  6. Egger M, Davey-Smith G. Misleading meta—analysis. BMJ 1995; 310: 752–4

    Article  PubMed  CAS  Google Scholar 

  7. Detsky AS, O’Rourke KO, Corey PN, et al. The hazards of using active clinic patients as a source of subjects for clinical studies. J Gen Intern Med 1988; 32: 260–6

    Article  Google Scholar 

  8. Sacket DL. Bias in analytical research. J Chronic Dis 1979; 32: 51–63

    Article  Google Scholar 

  9. Jariath N, Weinstein J. The Delphi methodology (part 2): a useful administrative approach. Can J Nurs Adm 1994; 7 (4): 7–20

    Google Scholar 

  10. Jones J, Hunter D. Consensus methods for medical and health services research. BMJ 1995; 311: 376–80

    Article  PubMed  CAS  Google Scholar 

  11. Barr J, Schumacher G. Using decision analysis to conduct pharmacoeconomic studies. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia: Lippincott—Raven Publishers, 1996: 1197–214

    Google Scholar 

  12. Williams P, Webb C. The Delphi technique: a methodological discussion. J Adv Nurs 1994; 19: 180–6

    Article  PubMed  CAS  Google Scholar 

  13. Evans C. The use of consensus methods and expert panels in pharmacoeconomic studies: practical applications and methodological shortcomings. Pharmacoeconomics 1997; 12 (2 Pt 1): 121–9

    Article  PubMed  CAS  Google Scholar 

  14. Nuijten MJC, Hardens M, Souetre E. A Markov process analysis comparing the cost effectiveness of maintenance therapy with citalopram versus standard therapy in major depression. Pharmacoeconomics. 1995; 8 (2): 159–168

    Article  PubMed  CAS  Google Scholar 

  15. Clinical practice guideline. Depression in primary care: treatment of major depression (AHCPR publication no. 93-0551). Rockville (MD): Public Health Service, Agency for Health Care Policy and Research, 1993

    Google Scholar 

  16. Rosenberg C, Damsbo N, Fuglum E, et al. Citalopram and imipramine in the treatment of depressive patients in general practice: a Nordic multicentre clinical study. Int Clin Psychopharmacol 1994; 9 Suppl. 1: 41–8

    Article  PubMed  Google Scholar 

  17. Rote Liste 1993. Arzneimittelverzeichnis des BPI. Aulendorf/Würtemberg: Edition Cantor Verlag für Medizin und Naturwissenschaften GmbH, 1993

    Google Scholar 

  18. BMA. Bewertungsmass—stab für kassenärtzliche Leistungen. Cologne: Deutscher Artze—Verlag GmbH, 1993

    Google Scholar 

  19. DOK-8: AOK-Bundesverband 1994 Apr 15: 256

  20. Montgomery SA, Rasmussen JGC, Tanghoi P. A 24−week study of 20 mg citalopram and placebo in the prevention of relapse of major depression. Int Clin Psychopharmacol 1993; 9: 181–8

    Article  Google Scholar 

  21. Clemens K, Townsend R, Luscombe F, et al. Methodological and conduct principles for pharmacoeconomic research. Pharmacoeconomics 1995; 8 (2): 169–74

    Article  PubMed  CAS  Google Scholar 

  22. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 1996; 313: 275–83.

    Article  PubMed  CAS  Google Scholar 

  23. Jefferson T, Demichelli V. Are guidelines for peer—reviewing economic evaluation necessary? A survey of current editorial practice. Health Econ 1995; 4: 383–8

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Lewin Group, Jupiterstraat 106, 2132 HE, Hoofddorp, The Netherlands

    Mark J. C. Nuijten

Authors
  1. Mark J. C. Nuijten
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark J. C. Nuijten.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nuijten, M.J.C. The Selection of Data Sources For Use in Modelling Studies. Pharmacoeconomics 13, 305–316 (1998). https://doi.org/10.2165/00019053-199813030-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199813030-00005

Keywords

Search

Navigation